UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by ICW Investment Advisors LLC

ICW Investment Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 7.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,668 shares of the healthcare conglomerate’s stock after buying an additional 110 shares during the quarter. ICW Investment Advisors LLC’s holdings in UnitedHealth Group were worth $802,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. 25 LLC acquired a new position in shares of UnitedHealth Group in the first quarter worth about $28,000. Cascade Investment Advisors Inc. acquired a new stake in UnitedHealth Group during the 1st quarter valued at $28,000. Kalos Management Inc. acquired a new stake in shares of UnitedHealth Group in the first quarter worth $34,000. Strategic Investment Solutions Inc. IL purchased a new stake in UnitedHealth Group in the 1st quarter worth about $35,000. Finally, Clear Investment Research LLC increased its holdings in shares of UnitedHealth Group by 216.7% in the 1st quarter. Clear Investment Research LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 52 shares during the period. 85.69% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. HSBC began coverage on shares of UnitedHealth Group in a research note on Wednesday, September 6th. They issued a “hold” rating and a $540.00 price objective on the stock. UBS Group raised UnitedHealth Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $520.00 to $640.00 in a research note on Monday, October 16th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a research note on Monday, October 23rd. Piper Sandler boosted their price objective on shares of UnitedHealth Group from $580.00 to $584.00 and gave the stock an “overweight” rating in a research note on Monday, October 16th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $564.00 to $555.00 in a report on Monday, July 17th. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $578.30.

Check Out Our Latest Stock Analysis on UNH

Insider Activity

In other news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the sale, the executive vice president now directly owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Stephen J. Hemsley sold 121,515 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the transaction, the director now owns 521,818 shares of the company’s stock, valued at approximately $282,084,374.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares in the company, valued at $5,017,173.04. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 0.2 %

Shares of UNH stock opened at $542.41 on Tuesday. The stock has a market cap of $501.69 billion, a price-to-earnings ratio of 23.54, a P/E/G ratio of 1.64 and a beta of 0.63. The firm has a fifty day moving average of $514.87 and a 200-day moving average of $497.20. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $553.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.80 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.33 by $0.23. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The business had revenue of $92.36 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the prior year, the firm posted $5.79 EPS. UnitedHealth Group’s quarterly revenue was up 14.2% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 24.94 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, December 4th will be paid a dividend of $1.88 per share. The ex-dividend date of this dividend is Friday, December 1st. This represents a $7.52 annualized dividend and a yield of 1.39%. UnitedHealth Group’s dividend payout ratio is 32.64%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.